OOIR: Observatory of International Research

Papers

(The median citation count of JAMA Psychiatry is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Error in Table	827
Error in Quiz Answer	613
Viewing Psychiatric Epidemiology Within a Global Historical Framework to Shape Future Practice	572
Examining Sex Differences in Autism Heritability	449
Stress as a Risk Factor for Mental Disorders in a Gendered Environment	433
Coding Error for the Sex Variable in a Meta-analysis	382
Error in Race and Ethnicity Data	358
Change to Open Access Status	332
Characteristics of Registered Clinical Trials Evaluating the Role of e-Cigarettes in Cessation or Reduction of Cigarette Smoking	316
Psychiatric, Neurological, and Somatic Comorbidities in Intermittent Explosive Disorder	273
Errors in Figure 2	252
Sex and Drug Overdose Mortality Trends, 1999-2020—Reply	221
Mental Health Diagnoses in People Experiencing Homelessness—Reply	213
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders	207
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis	185
Modifying Informed Consent to Help Address Functional Unmasking in Psychedelic Clinical Trials	176
Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression	169
Bright Light Therapy for Nonseasonal Depressive Disorders—Reply	169
JAMA Psychiatry	165
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk	162
Combining Antidepressants vs Antidepressant Monotherapy for Treatment of Patients With Acute Depression	156
Association of Implementation of Postoverdose Outreach Programs With Subsequent Opioid Overdose Deaths Among Massachusetts Municipalities	153
Population-Based Risk of Psychiatric Disorders Associated With Recurrent Copy Number Variants	146
Timing of Antidepressant Discontinuation During Pregnancy and Postpartum Psychiatric Outcomes in Denmark and Norway	139
Tax Policy—An Understudied Approach to Reducing Cannabis Use	137

Error in Text	133
Studying Healthy Psychosislike Experiences to Improve Illness Prediction	126
Insights on Neural Response to Racist Threats	120
How the Cognitive Science of Belief Can Transform the Study of Mental Health	119
Errors in Text and Table	116
Associating Violence With Schizophrenia—Risks and Biases	112
JAMA Psychiatry Editorial Fellow	111
Some Concerns About Imputation Methods for Missing Data—Reply	110
Data Errors in Table	110
Synaptic Density in Early Stages of Psychosis and Clinical High Risk	107
Errors in Figure 4	106
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure—Reply	106
COP27 Climate Change Conference—Urgent Action Needed for Africa and the World	106
Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey	105
JAMA Psychiatry	101
JAMA Psychiatry	100
Suicide Risk and Lithium	99
International Variation in Clozapine Hematologic Monitoring—A Call for Action	99
Further Considerations on Early Intervention for Borderline Personality Disorder—Reply	96
JAMA Psychiatry	93
JAMA Psychiatry	93
Error in Additional Contributions	92
SSRIs in Pregnancy—What Offspring Brain Volumes Can and Cannot Tell Us	90
The Reliability of Traumatic and Adverse Experiences	90
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	88
JAMA Psychiatry	88
Concerns About Data in Study Reporting an Association Between Abortion Restrictions and Suicide	87
Equity and the JAMA Network	86
Error in Text	84
Error in Results	84
Another Effort to Get People With Mental Illness Experiencing Homelessness Off the Streets—A Sound Idea?	84
Acknowledging Lack of Inclusion in Genetic Analyses—Reply	83
Evaluating the Liability of Antidepressants to Induce Mania in Children and Adolescents With Depression	80
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials	79
Variations in Suicide Risk and Risk Factors After Hospitalization for Depression in Finland, 1996-2017	78
Healing Ethno-Racial Trauma in Black Communities	77
Charting New Phenomenological Paths for Empirical Research on Delusions	76
Native Hawaiian and Pacific Islander Data in Overdose Research	75
Managerial and Organizational Challenges in the Age of AI	74
The Promise and Perils of Using Peers and Other Paraprofessionals as Mental Health Service Professionals	74
Race and Ethnicity of Editorial Board Members and Editors as an Indicator of Structural Racism in Psychiatry and Neuroscience Journals	73
Association of COVID-19 and Endemic Systemic Racism With Postpartum Anxiety and Depression Among Black Birthing Individuals	71
Potential Lessons for DSM From Contemporary Philosophy of Science	70
TikTok Challenges—Unintentional Injuries vs Suicide Attempts	69
Driving Performance and Cannabis Users’ Perception of Safety	68
Associating Violence With Schizophrenia—Risks and Biases	67
Pain Scores as Secondary Outcomes—Opioid Reduction Studies	66
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	66
Errors in Numbers in Meta-Analysis	66
Association Between Genetic Risk for Psychiatric Disorders and the Probability of Living in Urban Settings	65

Advancing Diversity, Equity, and Inclusion at JAMA Psychiatry	65
Rethinking Palliative Care in Psychiatry	64
Recommendation for Cannabis Use Disorder Diagnosis in a Context of Cannabis for Therapeutic Purposes	63
Is Anxiety in Late Life an Uncharted Territory?—Questioning the USPSTF Draft Recommendation Statement for Anxiety Screening in Older Adults	63
Assumptions and Limitations of the Synthetic Control Method	62
Suicide Attempts of Muslims Compared With Other Religious Groups in the US	61
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure	61
Being Precise About Precision Mental Health	61
Setting Limits With Controlled Substances—The Role of Motivational Interviewing to Increase Comfort	61
Errors in Text and Supplement	60
Alcohol Cue Processing in Co-Occurring Bipolar Disorder and Alcohol Use Disorder	60
Maternal Mental Health and Infant Development During the COVID-19 Pandemic	59
Changes in Attributable Fractions and Causal Inference for Schizophrenia and Other Psychiatric Outcomes	59
Racial/Ethnic, Social, and Geographic Trends in Overdose-Associated Cardiac Arrests Observed by US Emergency Medical Services During the COVID-19 Pandemic	58
Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression	58
Neurocognitive Development in Children at Familial High Risk of Schizophrenia or Bipolar Disorder	58
Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19	57
US Religious Leaders’ Views on the Etiology and Treatment of Depression	57
A Dynamical Systems View of Psychiatric Disorders—Practical Implications	57
Patterns of Brain Maturation in Autism and Their Molecular Associations	57
Does Microglial Activation Lead to Cognitive Changes After COVID-19 Infection?	57
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia	57
Posttraumatic Stress Disorder, Obesity, and Accelerated Epigenetic Aging Among US Military Veterans	55
Diagnosing and Treating ADHD in Adults	55
Moving Beyond Medications That Act at the μ Receptor in the Treatment of Opioid Use Disorder	55
Association of Single-blind Placebo Run-in Periods With the Placebo Response in Randomized Clinical Trials of Antidepressants	54
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level	54
Prevalence and Trends in Suicidal Behavior Among US Military Veterans During the COVID-19 Pandemic	54
Expectancy Effects, Failure of Blinding Integrity, and Placebo Response in Trials of Treatments for Psychiatric Disorders	54
Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal Youth	54
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	53
The Subjective Experience of Childhood Maltreatment in Psychopathology	52
Reinforcement Learning Disruptions in Individuals With Depression and Sensitivity to Symptom Change Following Cognitive Behavioral Therapy	52
Patterns of Neural Network Functional Connectivity Associated With Mania/Hypomania and Depression Risk in 3 Independent Young Adult Samples	52
Semaglutide in Psychiatry—Opportunities and Challenges	52
The Direct Effect of Cognitive Behavioral Therapy for Insomnia on Depression Prevention and the Mediation Effect via Insomnia Remission	52
Estimated Number of Children Who Lost a Parent to Drug Overdose in the US From 2011 to 2021	52
Family History of Psychiatric Disorders as a Risk Factor for Maternal Postpartum Depression	51
Association of Brain Reward Response With Body Mass Index and Ventral Striatal-Hypothalamic Circuitry Among Young Women With Eating Disorders	51
Deletion of Loss-of-Function–Intolerant Genes and Risk of 5 Psychiatric Disorders	51
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood	51
Effort-Cost Decision-making Among Individuals With Schizophrenia	50
Caring for Patients With Severe Anorexia Nervosa—A Capacity Evaluation Cannot Save Us	50
Changing Neighborhood Income Deprivation Over Time, Moving in Childhood, and Adult Risk of Depression	50
Neuropsychiatric and Cognitive Outcomes in Patients 6 Months After COVID-19 Requiring Hospitalization Compared With Matched Control Patients Hospitalized for Non–COVID-19 Illness	47
Cerebrospinal Fluid Biomarkers in Patients With Unipolar Depression Compared With Healthy Control Individuals	47
Clinical Outcomes of Continuation and Maintenance Electroconvulsive Therapy	46
Effect of an Emergency Department Process Improvement Package on Suicide Prevention	46
Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic	46
Ketamine vs Electroconvulsive Therapy for Major Depressive Episode	46
Trajectories of Adolescent Media Use and Their Associations With Psychotic Experiences	46
Association of Multigenerational Family History of Depression With Lifetime Depressive and Other Psychiatric Disorders in Children	45
Preaddiction—A Missing Concept for Treating Substance Use Disorders	45
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders	45
Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death	45
Association of History of Psychopathology With Accelerated Aging at Midlife	45
Differential Outcomes of Placebo Treatment Across 9 Psychiatric Disorders	45
Association of Oxidative Stress–Induced Nucleic Acid Damage With Psychiatric Disorders in Adults	45
Immediate and Sustained Outcomes and Moderators Associated With Metacognitive Training for Psychosis	44
Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy	44
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	44
Acceptability, Tolerability, and Estimates of Putative Treatment Effects of Probiotics as Adjunctive Treatment in Patients With Depression	43
Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder Across Neuroimaging Modalities	43
Association of 24-Hour Activity Pattern Phenotypes With Depression Symptoms and Cognitive Performance in Aging	42
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	42
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	42
Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic	42
Association of US Nurse and Physician Occupation With Risk of Suicide	41
Transcriptome-Wide Structural Equation Modeling of 13 Major Psychiatric Disorders for Cross-Disorder Risk and Drug Repurposing	41
Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Insomnia in Adults	40
Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia	40
Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance	40
Depression Associated With Hormonal Contraceptive Use as a Risk Indicator for Postpartum Depression	40
Abortion and Mental Health—Context and Common Ground	39
An Opportunity to Advance Cannabis Science—DEA Rescheduling	39
Association of Social Determinants of Health and Vaccinations With Child Mental Health During the COVID-19 Pandemic in the US	39
Considerations in Publishing a Psychiatric Randomized Clinical Trial With Kenyan Children	39
Multivariate, Transgenerational Associations of the COVID-19 Pandemic Across Minoritized and Marginalized Communities	38
Global Mental Health Services and the Impact of Artificial Intelligence–Powered Large Language Models	38
JAMA Psychiatry—The Year in Review, 2020	38

Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode	38
Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression	38
Trends in Incident Prescriptions for Behavioral Health Medications in the US, 2018-2022	37
Living Alone and Drug Overdose Deaths in the US	36
Some Concerns About Imputation Methods for Missing Data	36
JAMA Psychiatry	36
JAMA Psychiatry	36
Errors From Incorrect Use of Subscale	36
Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder	35
Evolutionary Inquiries Into the Origin and Nature of Mental Disorders	35
Errors in Figures 1 and 2	34
Errors in Statistical Results	33
JAMA Psychiatry Editorial Fellow	33
Perinatal Depression Screening Among Sexual Minority Women	33
JAMA Psychiatry	33
JAMA Psychiatry	32
Association of Major Disease Outbreaks With Adolescent and Youth Mental Health in Low- and Middle-Income Countries	32
Heritability of Psychotic Experiences in Adolescents and Interaction With Environmental Risk	32
Concerns Regarding Strength of Conclusions in Systematic Review and Meta-Analysis of Neuroradiological Abnormalities in First-Episode Psychosis—Reply	31
Applying Anti-racism to Clinical Care and Research	31
JAMA Psychiatry	31
Association of Lithium Treatment With the Risk of Osteoporosis in Patients With Bipolar Disorder	31
Error in Author Name Presentation	30
US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving	30
Dissimilar Control Interventions in Clinical Trials Undermine Interpretability—Reply	30
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents	30
Error in Table 1	30
Prefrontal γ-Aminobutyric Acid Levels in Never-Medicated Individuals With Chronic Schizophrenia	30
JAMA Psychiatry	29
Challenges to Behavioral Health and Injury Surveillance During the COVID-19 Pandemic—Reply	29
Improving the Assessment of COVID-19–Associated Posttraumatic Stress Disorder	29
Error in Tables	29
Dissimilar Control Interventions in Clinical Trials Undermine Interpretability	28
Bright Light Therapy for Nonseasonal Depressive Disorders	28
Evaluation of the Risk Identification for Suicide and Enhanced Care Model in a Native American Community	28
Cognitive Function in People With Familial Risk of Depression	28
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?	28
Informed Consent to Psychedelic Treatment—A Work in Progress	28
Errors in Relative Risks Reported in Figure 3 in a Network Meta-analysis of Cognitive Behavior Therapy Delivery Formats in Adults With Depression	28
Depressive Symptoms and Amyloid Pathology	28
JAMA Network Call for Papers on Health and the 2024 US Election	28
Error in Results and in the Figure 3B Label and Plotted Values	27
Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults	27
Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans	27
Public Sector Learning Health Care Systems—Improving Patient Experience, Workforce Well-Being, and Recovery Outcomes	27
Estimated Average Treatment Effect of Psychiatric Hospitalization in Patients With Suicidal Behaviors	27
Evaluation of Post–COVID-19 Cognitive Dysfunction: Recommendations for Researchers	26
Extrapharmacological Safety Topics in Psychedelic-Assisted Psychotherapy	26
Contrasting Case-Control and Normative Reference Approaches to Capture Clinically Relevant Structural Brain Abnormalities in Patients With First-Episode Psychosis Who Are Antipsychotic Naive	26
Advancing the Blueprint to Mental Health Parity Reform	26
Data Pollution in Neuropsychiatry—An Under-Recognized but Critical Barrier to Research Progress	26
Perinatal Mental Health Outcomes Following Natural Disasters	26
Climate Change and Mental Health—Time to Act Now	25
Psychopharmacology and Explanatory Pluralism	25
Examining Power Relations to Understand and Address Social Determinants of Vaccine Uptake	25
Association Between Physical Activity and Schizophrenia	25
Numerical Error in Results of Abstract and Article Text	25
Long-term Arrhythmia Detection Using an Implantable Loop Recorder in Patients Receiving Psychotropic Medication	25
Rate of Suicide Among Women Nurses Compared With Women in the General Population Before the COVID-19 Global Pandemic	24
Change to Open Access Status	24
JAMA Psychiatry	24
JAMA Psychiatry Peer Reviewers in 2021	24
Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth	24
Error in Results	24
Epidemiology of Untreated Psychoses in 3 Diverse Settings in the Global South	23
Characterizing and Coding Psychiatric Diagnoses Using Electronic Health Record Data	23
Rural-Urban Disparities in Video Telehealth Use During Rapid Mental Health Care Virtualization Among American Indian/Alaska Native Veterans	23
The Search for Clinically Useful Neuroimaging Markers of Depression—A Worthwhile Pursuit or a Futile Quest?	23
Identification of Suicide Attempt Risk Factors in a National US Survey Using Machine Learning	23
Social Determinants of Mental Health	23
Association of Childhood Adversities With Suicide Ideation and Attempts in Puerto Rican Young Adults	23
The Psychotherapy in MDMA-Assisted Psychotherapy	23
Error in the Caption of Figures 2, 3, 4, and 5 and in Supplement 1	23
Intergenerational Effects of Racism	22
The Direct Effect of Cognitive Behavioral Therapy for Insomnia on Depression Prevention and the Mediation Effect via Insomnia Remission—Reply	22
A Traitlike Dimension of Subjective Memory Concern Over 30 Years Among Adult Male Twins	22
Error in Byline	22
Errors in Data Set and Effect Sizes for 1 Study Included in Meta-analysis of Delay Discounting as a Transdiagnostic Process in Psychiatric Disorders	22
JAMA Psychiatry Editorial Fellow	22
Social Disconnection as a Global Behavioral Epidemic—A Call to Action About a Major Health Risk Factor	21
Community-Level Social Support Infrastructure and Adult Onset of Major Depressive Disorder in a South Asian Postconflict Setting	21
Estimated Prevalence of Perinatal Depression in Low- and Middle-Income Countries Considering Uncertainty of Test Properties—Reply	21
Digital Mental Health’s Unstable Dichotomy—Wellness and Health	21
Addiction Medicine Physicians and Medicinal Cannabinoids	21
Course of Subtypes of Late-Life Depression Identified by Bipartite Network Analysis During Psychosocial Interventions	21
Mental Health Service Use Before First Diagnosis of a Psychotic Disorder	21
Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder	21
Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation	21
Funding/Support Updated	20
Genes and Rearing—What Explains Intergenerational Transmission of PTSD?	20
Change to Open Access	20
Errors in Results and Supplement 1	20
Association of Emotion Regulation Trajectories in Childhood With Anorexia Nervosa and Atypical Anorexia Nervosa in Early Adolescence	20
Posttraumatic Stress Disorder in Patients After Severe COVID-19 Infection	19
Observational and Genetic Analyses of Traumatic Experiences and Endometriosis	19